发明授权
US08232069B2 Antibody directed against PAP2a and use thereof for diagnostic and therapeutic purposes
失效
针对PAP2a的抗体及其用于诊断和治疗目的的用途
- 专利标题： Antibody directed against PAP2a and use thereof for diagnostic and therapeutic purposes
- 专利标题（中）： 针对PAP2a的抗体及其用于诊断和治疗目的的用途
-
申请号： US11914618申请日： 2006-05-17
-
公开(公告)号： US08232069B2公开(公告)日： 2012-07-31
- 发明人: Hirofumi Hamada , Kiminori Nakamura , Kazunori Kato
- 申请人： Hirofumi Hamada , Kiminori Nakamura , Kazunori Kato
- 申请人地址： JP Hokkaido
- 专利权人： Sapporo Medical University
- 当前专利权人： Sapporo Medical University
- 当前专利权人地址： JP Hokkaido
- 代理机构： Foley & Lardner LLP
- 优先权： JP2005-143801 20050517; JP2005-202069 20050711
- 国际申请： PCT/JP2006/310406 WO 20060517
- 国际公布： WO2006/123829 WO 20061123
- 主分类号： G01N33/574
- IPC分类号： G01N33/574
摘要：
The present invention aims at developing a gene delivery system which has a high selectivity to a target cell and can introduce and express a gene with high efficiency, particularly developing such a system for use in a gene delivery therapy using a viral vector. The present invention provides a method for targeting a drug, which comprises the step of delivering a drug containing a therapeutic gene to a target site using an anti-PAP2a antibody.